Clinical Efficiency and Safety Analysis of Transcatheter Interventional Therapy for Compound Congenital Cardiovascular Abnormalities
Authors:
Open Access
- 10 October 2007
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 30 (10) , 518-521
Abstract
Objective: To investigate the efficiency and safety of transcatheter interventional therapy for compound congenital cardiovascular abnormalities.Methods: From Nov 2001 to Jun 2006, a total of 36 patients (17 male, 19 female), aged 17.20 ± 10.52, with compound congenital cardiovascular abnormalities underwent transcatheter interventional procedure. These patients included 11 with perimembranous ventricular septal defect (PVSD) and patent ductus arteriosus (PDA), 8 patients with PVSD and atrial septal defect (ASD), 8 patients with ASD and PDA, 7 patients with ASD and pulmonary stenosis (PS), 1 patient with ASD and mitral stenosis(MS), 1 patient with coarctation of aorta (COA) and PDA. According to the principle of “easy first, hard second,” balloon valvuloplasties of PS or MS were performed before the closure of PVSD, and of PDA and ASD. Electrocardiogram and transthoracic echocardiogram were examined at 4 days, 1, 2, 6 and 12 months, respectively, after each procedure.Results: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities was successful in all patients. Among these, 2 occluders were planted in each of 27 patients, 7 patients with ASD combined with PS and 1 patient with ASD combined with MS underwent successfully performed balloon valvuloplasty and ASD closure, 1 patient with COA combined with PDA underwent successfully performed balloon valvuloplasty and subsequent covered stent implantation. No patient encountered serious adverse events during the (30.5 ± 14.6) months of follow‐up.Conclusions: Transcatheter interventional therapy for compound congenital cardiovascular abnormalities could obtain satisfactory results with technical feasibility. CopyrightKeywords
This publication has 19 references indexed in Scilit:
- Technology Insight: transcatheter closure of ventricular septal defectsNature Clinical Practice Cardiovascular Medicine, 2005
- Multicenter Experience with Perventricular Device Closure of Muscular Ventricular Septal DefectsPediatric Cardiology, 2005
- Percutaneous Closure of Congenital and Acquired Ventricular Septal Defects—Considerations on Selection of the Occlusion DeviceJournal of Interventional Cardiology, 2005
- Multicenter USA Amplatzer Patent Ductus Arteriosus Occlusion Device TrialJACC, 2004
- Simultaneous device closure of muscular ventricular septal defect and pulmonary valve balloon dilatationCatheterization and Cardiovascular Interventions, 2003
- Long-term invasive and noninvasive results of percutaneous balloon pulmonary valvuloplasty in children, adolescents, and adultsAmerican Heart Journal, 1999
- Percutaneous closure of the small (< 2.5 mm) patent ductus arteriosus using coil embolizationThe American Journal of Cardiology, 1992
- Aortic balloon valvuloplastyAmerican Heart Journal, 1983
- Percutaneous Balloon Valvuloplasty: A New Method for Treating Congenital Pulmonary-Valve StenosisNew England Journal of Medicine, 1982
- Transposition of the Great ArteriesCirculation, 1968